Finance

Lists
ROVI:BME
Laboratorios Farmaceuticos ROVI SA
58,40 €
-0,17%
(-0,100) 1D
13-окт., 12:33:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ROVI...
Open
58,75 €
High
59,15 €
Low
58,35 €
Mkt. cap
2,99 млд
Avg. vol.
81,50 миң
Volume
14,37 миң
Dividend
1,64%
Quarterly dividend
0,24 €
Ex-dividend date
2026-ж., 13-июл.
P/E ratio
16,17
52-wk high
86,70 €
52-wk low
53,10 €
EPS
3,61 €
Shares outstanding
51,24 млн
No. of employees
2 миң
Open
58,75 €
High
59,15 €
Low
58,35 €
Mkt. cap
2,99 млд
Avg. vol.
81,50 миң
Volume
14,37 миң
Dividend
1,64%
Quarterly dividend
0,24 €
Ex-dividend date
2026-ж., 13-июл.
P/E ratio
16,17
52-wk high
86,70 €
52-wk low
53,10 €
EPS
3,61 €
Shares outstanding
51,24 млн
No. of employees
2 миң
News stories
From web sources and news partners
Profile
Laboratorios Farmaceuticos Rovi SA is a Spanish pharmaceutical company. The company is a member of the IBEX 35 stock market index. Wikipedia
About Laboratorios Farmaceuticos ROVI SA
CEO-
Employees2,47 миң
Founded1946
Headquarters-
SectorPharmaceutical industry
Websiterovi.es
Last report
2026-ж., 23-июл.
Fiscal period
Q2 2026
1,46 € / -
0,00%miss
Revenue / Est. (EUR)
344,16 млн / 179,82 млн
+91,39%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
210,47 млн
218,42 млн
152,49 млн
191,67 млн
Cost of goods sold
62,66 млн
90,33 млн
59,61 млн
60,04 млн
Cost of revenue
62,66 млн
90,33 млн
59,61 млн
60,04 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34,66 млн
55,40 млн
38,04 млн
47,22 млн
Operating expense
79,83 млн
73,16 млн
83,00 млн
113,58 млн
Total operating expenses
142,49 млн
163,49 млн
142,61 млн
173,62 млн
Operating income
67,98 млн
54,93 млн
9,89 млн
18,05 млн
Other non operating income
8,35 млн
3,80 млн
2,32 млн
10,64 млн
EBT including unusual items
75,70 млн
57,94 млн
12,29 млн
89,28 млн
EBT excluding unusual items
75,70 млн
57,94 млн
12,29 млн
26,93 млн
Income tax expense
17,68 млн
15,29 млн
2,84 млн
14,35 млн
Effective tax rate
23,36%
26,39%
23,11%
16,07%
Other operating expenses
37,70 млн
9,61 млн
36,79 млн
56,55 млн
Net income
58,03 млн
42,68 млн
9,48 млн
75,00 млн
Net profit margin
27,57%
19,54%
6,22%
39,13%
Earnings per share
-
-
-
-
Interest and investment income
86,00 миң
-
403,00 миң
474,00 миң
Interest expense
-757,00 миң
-767,00 миң
-782,00 миң
-1,97 млн
Net interest expenses
-671,00 миң
-767,00 миң
-379,00 миң
-1,50 млн
Depreciation and amortization charges
7,47 млн
8,16 млн
8,17 млн
9,81 млн
EBITDA
79,21 млн
55,10 млн
18,05 млн
23,60 млн
Gain or loss from assets sale
-
14,00 миң
1,77 млн
-2,00 миң
AI content may include mistakes. Learn more
Google колдонмолору